Platinum-based drugs in cancer treatment: Expanding horizons and overcoming resistance

M Shahlaei, SM Asl, A Derakhshani, L Kurek… - Journal of Molecular …, 2024 - Elsevier
Platinum-based drugs have maintained their preeminent position in cancer treatment
regimens even four decades after the approval of cisplatin. Although these agents have …

Platinum-based chemotherapy: trends in organic nanodelivery systems

JAV Santos, D Silva, MPM Marques, LAEB de Carvalho - Nanoscale, 2024 - pubs.rsc.org
Despite the investment in platinum drugs research, cisplatin, carboplatin and oxaliplatin are
still the only Pt-based compounds used as first line treatments for several cancers, with a few …

Poly (amidoamine) Dendrimers in Cancer Therapy: Chemotherapy, Radiotherapy and Imaging Advances

M Ahmadi Kamalabadi, S Kazempour… - Iranian Journal of Blood …, 2024 - ijbc.ir
Cancer is estimated to overtake cardiovascular diseases and take the top spot as the
leading and most important cause of mortality globally in the near future. Given the …

Assessing the role of JNK in human endothelial cell death induced by anti-cancer therapies

A McCulloch - 2024 - stax.strath.ac.uk
Cardiovascular disease is a common side effect of cancer treatment, particularly in those
who have been disease-free for over 10 years. Several studies have shown that radiation …

[引用][C] Recent Developments of Platinum-based Antitumor Drugs

M Sinan